Janux Therapeutics · 3 months ago
Senior Director, Biometrics
Janux Therapeutics is seeking a Senior Director, Biometrics to provide strategic leadership and vision for the Biometrics function. This role involves overseeing the design, analysis, and interpretation of clinical and preclinical studies, setting departmental strategy, and ensuring data integrity and regulatory compliance.
BiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics
Responsibilities
Establish and lead a premier Biometrics department, attracting, developing, and retaining top talent in Data Management, Biostatistics, and Statistical Programming
Actively engage in the design and analysis of clinical trials and preclinical studies
Lead cross-functional initiatives to advance clinical development and regulatory success
Develop and implement statistical analysis plans, including hands-on statistical programming and data analysis as needed
Collaborates closely with Clinical Development and Operations, Regulatory Affairs, Biomarkers, and Data Management teams to ensure robust study designs and accurate data interpretation
Foster synergies between functional areas to support the efficient development of high-quality study deliverables
Provide statistical input and support for regulatory submissions and interactions with health authorities
Ensures the statistical integrity of protocols, statistical analysis plans, clinical study reports, presentations, and publications of clinical trial data
Work with internal and external stakeholders in the design, collection, analysis, reporting, interpretation, and publication of clinical trial data
Set the strategic direction for the Biometrics department, aligning goals with organizational objectives and long-term growth; develop budgets, set priorities, ensure consistency and adherence to standards, and create departmental SOPs
Drive the development and implementation of new innovations, standards, processes, and programming efficiencies across biometrics
Maintain a broad understanding of relevant external trends, anticipates emerging issues, identifies strategic needs in technical knowledge, and sets the strategic direction to meet regulatory, scientific, and business needs
Oversee CRO biometrics deliverables, including but not limited to database and CRF development, statistical analysis plans, and interim and final TLF deliverables, ensuring quality and alignment with organizational goals and objectives
Represents the organization at professional societies, external scientific forums, and industry-wide technical discussions, as applicable
Ensure the statistical integrity of all deliverables and compliance with regulatory requirements
Lead quality assurance initiatives and corrective action planning
Provide expertise and consultation as a subject matter expert to project teams and serves as a key point of contact with senior management to continuously assess and improve operational project delivery
Monitor the qualitative and quantitative progress of biometrics implementation activities; oversees study reporting and tracks key indicators for performance and progress evaluation
Ensure consistent use of study tools, training materials, and compliance with standard processes, policies, and procedures
Other duties as assigned or deemed necessary by management
Qualification
Required
Ph.D. or Master's degree in Biostatistics, Statistics, or a related field
Minimum of 10 years of experience in biostatistics within biotech or pharmaceutical environments, with 5+ years in a senior leadership role
Demonstrated success in leading biometrics teams through all phases of drug development, including regulatory submissions and health authority interactions
Strong Phase III statistical planning background
Proven track record of strategic planning, innovation, and cross-functional leadership
Expertise in statistical software (e.g., SAS, R), data management tools, EDC platforms, and CDISC standards
Strong executive presence, communication, and interpersonal skills
Ability to influence and collaborate at all levels of the organization
Benefits
401K
Medical insurance
Dental insurance
Vision insurance
Supplemental disability insurance plans
Flexible schedule
Life insurance
Flexible vacation
Sick time
Incentive stock option plan
Relocation assistance
Company
Janux Therapeutics
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Funding
Current Stage
Public CompanyTotal Funding
$898.94MKey Investors
RA Capital ManagementAvalon Ventures
2024-12-03Post Ipo Equity· $350M
2024-02-29Post Ipo Equity· $296.5M
2023-07-17Post Ipo Equity· $60M
Leadership Team
Recent News
2025-12-24
2025-12-04
2025-12-03
Company data provided by crunchbase